临床路径之高血压脑出血外科治疗

2015-12-11 伊文 Neurosurgery

        高血压脑出血临床路径标准住院流程 (一)适用对象 第一诊断为高血压脑出血(ICD-10:I61.902)拟行开颅血肿清除术或穿刺血肿碎吸术(ICD-9:01.23006或ICD-901.39013)。 (二)诊断依据 根据《临床诊疗指南-神经外科学分册》(中华医学会编著,人民卫生出版社,2006年,第1版)、《临床技

        高血压脑出血临床路径标准住院流程

(一)适用对象

第一诊断为高血压脑出血(ICD-10:I61.902)拟行开颅血肿清除术或穿刺血肿碎吸术(ICD-9:01.23006或ICD-901.39013)。

(二)诊断依据

根据《临床诊疗指南-神经外科学分册》(中华医学会编著,人民卫生出版社,2006年,第1版)、《临床技术操作规范-神经外科分册》(中华医学会编著,人民军医出版社,2007年,第1版)、《王忠诚神经外科学》(王忠诚主编,湖北科学技术出版社,2005年,第1版)、《神经外科学》(赵继宗主编,人民卫生出版社,2007年,第1版)。

1.临床表现:

(1)明确的高血压病史;

(2)急性颅内压增高症状:常出现剧烈头痛、头晕及呕吐,严重病人可出现意识障碍。常经过几分钟至几小时的平稳期后出现进行性加重;

(3)神经系统症状:根据不同的出血部位,可以出现一些相应部位的对应症状,出现不同程度的偏瘫,偏身感觉障碍,偏盲,瞳孔改变及共济障碍:

①壳核出血:高血压脑出血最好发部位,先出现对侧肢体偏瘫,严重时可发展为昏迷甚至死亡;

②丘脑出血:一般出现对侧半身感觉障碍,当内囊出血时也出现偏瘫症状;

③小脑出血:由于对脑干的直接压迫,病人先出现昏迷而非先出现偏瘫;

④脑叶出血:症状因血肿所在脑叶不同而有所差异,如额叶可出现对侧偏瘫,多发生于上肢,下肢和面部较轻;顶叶可出现对侧半身感觉障碍;枕叶可出现同侧眼痛和对侧同向偏盲;颞叶出血如发生在优势半球,可出现语言不流利和听力障碍。

2.辅助检查:

(1)头颅CT扫描:是高血压脑出血的首选检查,明确出血部位和体积,血肿呈高密度影。

(2)头颅MRI扫描:不做为首选检查,该项检查有助于鉴别诊断。

(三)治疗方案的选择

根据《临床诊疗指南-神经外科学分册》(中华医学会编著,人民卫生出版社,2006年,第1版)、《临床技术操作规范-神经外科分册》(中华医学会编著,人民军医出版社,2007年,第1版)、《王忠诚神经外科学》(王忠诚主编,湖北科学技术出版社,2005年,第1版)、《神经外科学》(赵继宗主编,人民卫生出版社,2007年,第1版)。

1.手术适应征:

(1)病人出现意识障碍,或者无论血肿部位如何,病情迅速恶化者;

(2)幕上血肿量>30ml,中线结构移位>1cm者。幕下血肿量>10ml,有脑干或第四脑室受压者;

(3)血肿位于壳核或经壳核向苍白球及丘脑扩展,未破入脑室系统;

(4)经内科保守治疗无效,病情继续加重,无手术绝对禁忌症。

2.禁忌症:

(1)有严重心脏病、显著肝肾功能不全等,全身情况差,不能耐受手术者;

(2)脑疝晚期。

3.手术方式的选择:手术方式可分为开颅血肿清除术和穿刺血肿碎吸术。对于手术风险较大者(高龄、妊娠期、合并较严重的内科疾病者),

要向病人或家属仔细交待病情,如不同意手术,应履行签字手续,并予以严密观察。

(四)标准住院日为21天。

(五)进入路径标准

第一诊断符合ICD-10:I61.902

高血压脑出血疾病编码。当病人同时合并其他疾病诊断,但在住院期间不需特殊处理,也不影响第一诊断的临床路径流程实施时,可以进入路径。脑疝晚期病人不进入路径。

(六)术前准备(入院当天)

1.必需的检查项目:

(1)血常规、血型;

(2)尿常规;

(3)凝血功能;

(4)肝肾功能、血电解质、血糖;

(5)感染性疾病筛查(乙肝,丙肝,艾滋病,梅毒);

(6)胸部X-线平片,心电图;

(7)头颅CT扫描。

2.根据病人病情,必要时行心、肺功能检查,必要时可行DSA、MRI进行鉴别诊断。

(七)预防性抗菌药物选择与使用时机

按照《抗菌药物临床应用指导原则》(卫医发[2004]285号)和《抗菌药物临床应用指南》(汪复等主编,人民卫生出版社,2008年)执行。

(八)手术日为入院当天

1.麻醉方式:全身麻醉;

2.手术方式:开颅血肿清除术或穿刺血肿碎吸术;

3.手术置入物:颅骨、硬脑膜修复材料,颅骨固定材料,引流管系统;

4.术中用药:脱水药、激素、抗生素,关颅时应用抗癫痫药物;

5.输血:视手术出血情况决定。

(九)术后住院恢复20天

1.必须复查的检查项目:术后当日、术后第7天、术后2周复查头颅CT了解颅内情况,化验室检查包括血常规、肝肾功能、血电解质、血糖等;

2.根据病人病情,建议可行血气分析、胸部X-线平片、B超等检查;

3.每2-3天手术切口换药一次;

4.术后7天拆除手术切口缝线,或根据病情酌情延长时间;

5.术后根据具体病情,行气管切开术。

(十)出院标准

1.病人病情稳定,生命体征平稳;

2.体温正常,与手术相关各项化验无明显异常;

3.手术切口愈合良好;

4.仍处于昏迷状态的病人,估计不能短时间恢复者,如果生命体征平稳,可以转院继续康复治疗。

(十一)变异及原因分析

1.术中或术后继发手术部位或其他部位的颅内血肿、脑水肿等并发症,严重者或其他情况需要二次手术,导致住院时间延长、费用增加;

2.术后术后切口、颅内感染,出现严重神经系统并发症,导致住院时间延长与费用增加;

3.术后继发其他内、外科疾病,如肺部感染、下肢深静脉血栓、应激性溃疡等,需进一步诊治,导致住院时间延长。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=48529, encodeId=c6e2485296e, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:25:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46937, encodeId=f8f54693e4d, content=都是路径, beContent=null, objectType=article, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Dec 21 09:07:00 CST 2015, time=2015-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46736, encodeId=52ba46e36e6, content=科普性质吧基本每个患者都是这么做的, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Sat Dec 19 13:47:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46402, encodeId=6f74464022a, content=这也能投?, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLBzoPY0a1ZQrECBF90v8AkFiaxRlNpGj1mLzD1B7ibnyBjmDEjiauBSDpOw6w4tI7YxmjdWaIW0SXL4/0, createdBy=35951605658, createdName=等你一年又一年, createdTime=Wed Dec 16 16:27:00 CST 2015, time=2015-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45803, encodeId=82524580332, content=………, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=554a1670659, createdName=yuwenpsy, createdTime=Sun Dec 13 22:32:00 CST 2015, time=2015-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45706, encodeId=556c45e0638, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45707, encodeId=2c5445e07e3, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45708, encodeId=b1e545e085e, content=知道了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45631, encodeId=ab1945631ae, content=这可以吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd261670317, createdName=科研小旋风, createdTime=Fri Dec 11 23:32:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2015-12-26 hixiaoluo

    好文章,值得看。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=48529, encodeId=c6e2485296e, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:25:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46937, encodeId=f8f54693e4d, content=都是路径, beContent=null, objectType=article, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Dec 21 09:07:00 CST 2015, time=2015-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46736, encodeId=52ba46e36e6, content=科普性质吧基本每个患者都是这么做的, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Sat Dec 19 13:47:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46402, encodeId=6f74464022a, content=这也能投?, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLBzoPY0a1ZQrECBF90v8AkFiaxRlNpGj1mLzD1B7ibnyBjmDEjiauBSDpOw6w4tI7YxmjdWaIW0SXL4/0, createdBy=35951605658, createdName=等你一年又一年, createdTime=Wed Dec 16 16:27:00 CST 2015, time=2015-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45803, encodeId=82524580332, content=………, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=554a1670659, createdName=yuwenpsy, createdTime=Sun Dec 13 22:32:00 CST 2015, time=2015-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45706, encodeId=556c45e0638, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45707, encodeId=2c5445e07e3, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45708, encodeId=b1e545e085e, content=知道了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45631, encodeId=ab1945631ae, content=这可以吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd261670317, createdName=科研小旋风, createdTime=Fri Dec 11 23:32:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2015-12-21 milkshark

    都是路径

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=48529, encodeId=c6e2485296e, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:25:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46937, encodeId=f8f54693e4d, content=都是路径, beContent=null, objectType=article, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Dec 21 09:07:00 CST 2015, time=2015-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46736, encodeId=52ba46e36e6, content=科普性质吧基本每个患者都是这么做的, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Sat Dec 19 13:47:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46402, encodeId=6f74464022a, content=这也能投?, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLBzoPY0a1ZQrECBF90v8AkFiaxRlNpGj1mLzD1B7ibnyBjmDEjiauBSDpOw6w4tI7YxmjdWaIW0SXL4/0, createdBy=35951605658, createdName=等你一年又一年, createdTime=Wed Dec 16 16:27:00 CST 2015, time=2015-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45803, encodeId=82524580332, content=………, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=554a1670659, createdName=yuwenpsy, createdTime=Sun Dec 13 22:32:00 CST 2015, time=2015-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45706, encodeId=556c45e0638, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45707, encodeId=2c5445e07e3, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45708, encodeId=b1e545e085e, content=知道了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45631, encodeId=ab1945631ae, content=这可以吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd261670317, createdName=科研小旋风, createdTime=Fri Dec 11 23:32:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2015-12-19 inter158

    科普性质吧基本每个患者都是这么做的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=48529, encodeId=c6e2485296e, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:25:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46937, encodeId=f8f54693e4d, content=都是路径, beContent=null, objectType=article, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Dec 21 09:07:00 CST 2015, time=2015-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46736, encodeId=52ba46e36e6, content=科普性质吧基本每个患者都是这么做的, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Sat Dec 19 13:47:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46402, encodeId=6f74464022a, content=这也能投?, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLBzoPY0a1ZQrECBF90v8AkFiaxRlNpGj1mLzD1B7ibnyBjmDEjiauBSDpOw6w4tI7YxmjdWaIW0SXL4/0, createdBy=35951605658, createdName=等你一年又一年, createdTime=Wed Dec 16 16:27:00 CST 2015, time=2015-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45803, encodeId=82524580332, content=………, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=554a1670659, createdName=yuwenpsy, createdTime=Sun Dec 13 22:32:00 CST 2015, time=2015-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45706, encodeId=556c45e0638, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45707, encodeId=2c5445e07e3, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45708, encodeId=b1e545e085e, content=知道了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45631, encodeId=ab1945631ae, content=这可以吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd261670317, createdName=科研小旋风, createdTime=Fri Dec 11 23:32:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2015-12-16 等你一年又一年

    这也能投?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=48529, encodeId=c6e2485296e, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:25:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46937, encodeId=f8f54693e4d, content=都是路径, beContent=null, objectType=article, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Dec 21 09:07:00 CST 2015, time=2015-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46736, encodeId=52ba46e36e6, content=科普性质吧基本每个患者都是这么做的, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Sat Dec 19 13:47:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46402, encodeId=6f74464022a, content=这也能投?, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLBzoPY0a1ZQrECBF90v8AkFiaxRlNpGj1mLzD1B7ibnyBjmDEjiauBSDpOw6w4tI7YxmjdWaIW0SXL4/0, createdBy=35951605658, createdName=等你一年又一年, createdTime=Wed Dec 16 16:27:00 CST 2015, time=2015-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45803, encodeId=82524580332, content=………, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=554a1670659, createdName=yuwenpsy, createdTime=Sun Dec 13 22:32:00 CST 2015, time=2015-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45706, encodeId=556c45e0638, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45707, encodeId=2c5445e07e3, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45708, encodeId=b1e545e085e, content=知道了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45631, encodeId=ab1945631ae, content=这可以吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd261670317, createdName=科研小旋风, createdTime=Fri Dec 11 23:32:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2015-12-13 yuwenpsy

    ………

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=48529, encodeId=c6e2485296e, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:25:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46937, encodeId=f8f54693e4d, content=都是路径, beContent=null, objectType=article, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Dec 21 09:07:00 CST 2015, time=2015-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46736, encodeId=52ba46e36e6, content=科普性质吧基本每个患者都是这么做的, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Sat Dec 19 13:47:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46402, encodeId=6f74464022a, content=这也能投?, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLBzoPY0a1ZQrECBF90v8AkFiaxRlNpGj1mLzD1B7ibnyBjmDEjiauBSDpOw6w4tI7YxmjdWaIW0SXL4/0, createdBy=35951605658, createdName=等你一年又一年, createdTime=Wed Dec 16 16:27:00 CST 2015, time=2015-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45803, encodeId=82524580332, content=………, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=554a1670659, createdName=yuwenpsy, createdTime=Sun Dec 13 22:32:00 CST 2015, time=2015-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45706, encodeId=556c45e0638, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45707, encodeId=2c5445e07e3, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45708, encodeId=b1e545e085e, content=知道了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45631, encodeId=ab1945631ae, content=这可以吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd261670317, createdName=科研小旋风, createdTime=Fri Dec 11 23:32:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2015-12-12 zm0805

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=48529, encodeId=c6e2485296e, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:25:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46937, encodeId=f8f54693e4d, content=都是路径, beContent=null, objectType=article, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Dec 21 09:07:00 CST 2015, time=2015-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46736, encodeId=52ba46e36e6, content=科普性质吧基本每个患者都是这么做的, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Sat Dec 19 13:47:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46402, encodeId=6f74464022a, content=这也能投?, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLBzoPY0a1ZQrECBF90v8AkFiaxRlNpGj1mLzD1B7ibnyBjmDEjiauBSDpOw6w4tI7YxmjdWaIW0SXL4/0, createdBy=35951605658, createdName=等你一年又一年, createdTime=Wed Dec 16 16:27:00 CST 2015, time=2015-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45803, encodeId=82524580332, content=………, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=554a1670659, createdName=yuwenpsy, createdTime=Sun Dec 13 22:32:00 CST 2015, time=2015-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45706, encodeId=556c45e0638, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45707, encodeId=2c5445e07e3, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45708, encodeId=b1e545e085e, content=知道了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45631, encodeId=ab1945631ae, content=这可以吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd261670317, createdName=科研小旋风, createdTime=Fri Dec 11 23:32:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2015-12-12 zm0805

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=48529, encodeId=c6e2485296e, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:25:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46937, encodeId=f8f54693e4d, content=都是路径, beContent=null, objectType=article, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Dec 21 09:07:00 CST 2015, time=2015-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46736, encodeId=52ba46e36e6, content=科普性质吧基本每个患者都是这么做的, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Sat Dec 19 13:47:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46402, encodeId=6f74464022a, content=这也能投?, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLBzoPY0a1ZQrECBF90v8AkFiaxRlNpGj1mLzD1B7ibnyBjmDEjiauBSDpOw6w4tI7YxmjdWaIW0SXL4/0, createdBy=35951605658, createdName=等你一年又一年, createdTime=Wed Dec 16 16:27:00 CST 2015, time=2015-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45803, encodeId=82524580332, content=………, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=554a1670659, createdName=yuwenpsy, createdTime=Sun Dec 13 22:32:00 CST 2015, time=2015-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45706, encodeId=556c45e0638, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45707, encodeId=2c5445e07e3, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45708, encodeId=b1e545e085e, content=知道了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45631, encodeId=ab1945631ae, content=这可以吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd261670317, createdName=科研小旋风, createdTime=Fri Dec 11 23:32:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2015-12-12 zm0805

    知道了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=48529, encodeId=c6e2485296e, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:25:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46937, encodeId=f8f54693e4d, content=都是路径, beContent=null, objectType=article, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Dec 21 09:07:00 CST 2015, time=2015-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46736, encodeId=52ba46e36e6, content=科普性质吧基本每个患者都是这么做的, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Sat Dec 19 13:47:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46402, encodeId=6f74464022a, content=这也能投?, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLBzoPY0a1ZQrECBF90v8AkFiaxRlNpGj1mLzD1B7ibnyBjmDEjiauBSDpOw6w4tI7YxmjdWaIW0SXL4/0, createdBy=35951605658, createdName=等你一年又一年, createdTime=Wed Dec 16 16:27:00 CST 2015, time=2015-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45803, encodeId=82524580332, content=………, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=554a1670659, createdName=yuwenpsy, createdTime=Sun Dec 13 22:32:00 CST 2015, time=2015-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45706, encodeId=556c45e0638, content=哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45707, encodeId=2c5445e07e3, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45708, encodeId=b1e545e085e, content=知道了, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19691629579, createdName=zm0805, createdTime=Sat Dec 12 16:22:00 CST 2015, time=2015-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45631, encodeId=ab1945631ae, content=这可以吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd261670317, createdName=科研小旋风, createdTime=Fri Dec 11 23:32:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2015-12-11 科研小旋风

    这可以吗

    0

相关资讯

Front Neurol Neurosci:脑出血发生的流行病学

脑出血(ICH)的总发病率为24.6/100000人/年,并死亡率较高。了解脑出血发生的危险因素,制定主要预防策略。本文提供了脑出血发病率及ICH相关的危险因素的更新。方法:研究者检索了MEDLINE数据库(1980年到2014年10间)进行系统评价,ICH的流行病学,从原始文献中寻找ICH发生的频率及发现ICH相关危险因素的。结果:在过去的30年间,ICH发生并未改变,这可能与ICH患者危险因素

Stroke:中年人轻度饮酒与卒中和脑出血的发生无关,但中重度有害

背景和目的:在美国饮酒是非常常见的,并且少量或中等量的酒精对心血管系统是有利的。酒精与卒中发生的关系仍然存在争议。在两种人的队列研究中,研究人员调查了自称饮酒的中年人和缺血性卒中和脑出血(ICH)发生的关系。方法:在社区动脉粥样硬化风险研究中,12433名从未饮酒或当前正在饮酒者,年龄45到64岁。受试者自称每周常饮啤酒,白酒或烈酒。研究人员校正性别,种族后,用多变量Cox风险比例回归评估与从未饮

Stroke:预防性抗癫痫药物对脑出血患者预后的影响

目前对脑出血(ICH)后抗癫痫药物(AED)预防的作用仍不清楚。该分析在一项前瞻性队列研究中描述了预防性AED的使用率,并测试它与预后较差相关的假说。该分析包括744例ICH患者,这些患者在2012年11月前参与了脑内出血(ERICH)的民族/种族的变化研究。研究人员对基线临床特征和AED的使用以标准的方式进行了记录。在基线影像学记录了脑出血的位置和体积。研究人员通过AED预防分析了患者特征差异,

JAMA Neurol:治疗血栓溶解后脑出血——缩短诊断时间是关键

 使用重组血纤维蛋白溶酶原激活物(rtPA)治疗静脉血栓可以在四个半小时内改善缺血性卒中结果。但是,最为严重的并发症是有症状的脑出血(sICH),这一并发症发生率达6%。sICH尽管复发率很低,但其死亡率接近50%。目前治疗sICH主要是依据专家的建议,对于治疗的有效性的相关数据是很缺乏的。为了更好地了解血栓溶解相关的sICH的具体情况以及各种治疗方法的有效性。研究人员开展了一项多中心回

Medicine:HCV感染者脑出血风险增加,尤其是年轻患者

本研究探讨丙型肝炎病毒(HCV)感染是否可导致脑出血。在台湾国家健康保险数据中,2000年和2010年诊断为丙型肝炎病毒感染的患者9023名,按照年龄,性别配对随机选出无HCV感染的受试者36092名。在2011年底评估HCV感染患者ICH发生的风险,及受试者糖尿病,高血压合,缺血性心脏病,高脂血症,心房纤颤,酒精性肝疾病,颅脑损伤等共存病。应用多变量COX回归分析评估,HCV感染的患者比对照组受

Acta Neurochir:性爱可促发脑出血

背景:有报道称脑出血(ICH)与性活动相关。一组性活动后发生ICH患者进一步探索生理学性活动可促发ICH的发生。方法:回顾性研究医疗记录,识别与性爱相关的ICH的患者。收集临床和影像学资料。结果:共有16名与性爱相关非创伤性ICH患者。8名(50%)存在蛛网膜下动脉瘤出血,4名(25%)患者发生造影阴性的蛛网膜下出血,2名(12.5%)患者动静脉畸形,2名(12.5%)脑基底节区出血。平均年龄49